ORTEXORTEX News
Tracking ZBRA? Get live short interest, options flow, and signals on ORTEX.Sign up free →
ZB
Trader NoteZBRA

ZBRA heads into November earnings with shorts retreating and Street targets rising

Edited by Peter Hillerberg3 min readdata as of 19 Oct 2026, 17:33

Stories are generated from ORTEX data and reviewed by the ORTEX team. How we publish

ShareXLinkedInReddit

Zebra Technologies enters its November 3 earnings report with an unusual configuration: short sellers have been exiting, analyst targets are moving higher, and the stock still trades below the consensus price target despite a strong year.

The clearest shift in positioning is the pullback in short interest. Bears have covered heavily over the past month, with short interest down more than 11% over 30 days to 3.2% of the free float. The weekly move alone was a 9.3% reduction in shares short. At that level, with borrow availability running at over 6,600%, the lending market is completely unconstrained. There is no squeeze mechanic here, and no meaningful friction for anyone who wants to add or cover a position. Cost to borrow has ticked up 23% on the week to 0.64%, but that remains firmly in the "low" bracket and the absolute level is trivial. The options market is similarly unexcited: the put/call ratio at 1.46 is running just slightly below its 20-day average of 1.50, a z-score of minus 0.21, meaning hedging demand is neither elevated nor unusually absent. Positioning, taken as a whole, looks calm rather than charged.

Where the story gets more interesting is on the Street. Analysts moved targets higher across the board in the past two weeks, with Barclays lifting to $416 (Overweight) and Citigroup nudging to $400 (Neutral) both filed on October 12. The consensus mean price target now sits at roughly $415, about 12% above the current price of $369. Bulls cite the Q1 2026 print as evidence: $1.495 billion in sales, 4.3% organic growth, a 23.2% adjusted EBITDA margin, and a raised full-year organic growth outlook of 3 to 7%. The Elo Touch acquisition and its targeted $25 million in annual EBITDA synergies by year three add to the growth narrative. The forward earnings revision picture is particularly striking: the 12-month forward EPS year-on-year increase ranks in the 99th percentile of the ORTEX universe, the single highest factor score on the sheet.

Bears take the opposite read on the same facts. Concentration risk is a real concern: three distributors account for 50% of sales, which leaves the revenue line vulnerable if enterprise capital spending slows. The refresh cycle for barcode scanners and mobile computing equipment is long, and any delay by large logistics or retail customers flows directly into Zebra's order book. Memory cost pressures and tariff risk around the supply chain add margin uncertainty even if topline growth holds. The stock's trailing PE of about 16.7 times and EV/EBITDA of 13.2 times are not demanding multiples for a company with this growth profile, but the price-to-book at 4.1 times leaves little cushion if margins disappoint. The stock has also given back 4.7% on the week, partly retracing its 7.7% one-month gain.

The most striking recent data point on the stock is its Wikipedia attention signal. The Wikimedia Foundation dataset, which tracks retail interest via English-language page views alongside ORTEX stock page traffic, posted a z-score of 1.88 against the company's own prior 90 days as of late September. That is elevated attention by Zebra's own history, though the dataset has not been measured to lead the company's reported financial figures, so it is colour rather than a forward indicator.

Among correlated peers, NOVT fell 8.8% on the week, the sharpest drop in the group, while ITRI was down 3.0% and TEL off 2.6%. Zebra's 4.7% weekly decline puts it in the weaker half of its peer group but not at the extreme. The November 3 earnings date is now 15 days out. The last print delivered a one-day move of plus 26.5% and a five-day move of plus 31.3%, by some distance the largest earnings reaction in the recent history of the stock. What to watch next is whether the raised full-year guidance from Q1 holds, and whether the Elo Touch integration is tracking ahead of, in line with, or behind the synergy schedule.

Stocks in this article

See the live data behind this article on ORTEX.

Open ZBRA on ORTEX →

How this article was generated

Generated
19 Oct 2026, 17:33
Data as of
19 Oct 2026, 17:33
Prompt version
v1.0
Data sources
Short interestCost to borrowUtilizationOptions flowEarningsAnalyst consensusInstitutional positioningORTEX Alpha signalsRecent ORTEX notesAlt Data

ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data and reviewed by the ORTEX team. Content is informational only and does not constitute investment advice.